*Zomato Limited : Alipay Singapore Holding Pte. Ltd. Sell 262873507 Shares @ Rs. 62.06
*Zomato Limited : Camas Investments Pte. Ltd. Buy 98000000 Shares @ Rs. 62
*Varun Beverages Limited : Integrated Core Strategies (Asia) Pte. Ltd. Sell 4806216 Shares @ Rs. 1245.01
*Tube Invest Of India Ltd : Integrated Core Strategies (Asia) Pte. Ltd. Sell 1735111 Shares @ Rs. 2766.83
*Indian Hotels Co. Ltd. : Integrated Core Strategies (Asia) Pte. Ltd. Sell 14437430 Shares @ Rs. 321.47
*Tvs Motor Company Limited : Integrated Core Strategies (Asia) Pte. Ltd. Sell 3977007 Shares @ Rs. 1046.69
*Bajaj Holdings & Invs Ltd : Integrated Core Strategies (Asia) Pte. Ltd. Sell 583876 Shares @ Rs. 6266.25
*Abb India Limited : Integrated Core Strategies (Asia) Pte. Ltd. Sell 1090479 Shares @ Rs. 2997.22
*Indian Hotels Co. Ltd. : Government Of Singapore Invt Corpn Pte Ltd A/C C Account Buy 9474188 Shares @ Rs. 321.77
*Tvs Motor Company Limited : Government Of Singapore Invt Corpn Pte Ltd A/C C Account Buy 2469940 Shares @ Rs. 1047.81
*Indian Hotels Co. Ltd. : Bnp Paribas Arbitrage Sell 7227509 Shares @ Rs. 321.83
*Likhitha Infrastruc Ltd : Ashish Kacholia Buy 397000 Shares @ Rs. 386
*Nureca Limited : Hornbill Orchid India Fund Sell 97000 Shares @ Rs. 518.32
*Accuracy Shipping Limited : Antara India Evergreen Fund Ltd Buy 260000 Shares @ Rs. 184.93
*Indian Hotels Co. Ltd. : Bnp Paribas Arbitrage Buy 32536 Shares @ Rs. 322.39
*SANJAY MOHAN LABROO Promoter Group Acquisition 144000 shares of Mahindra & Mahindra Ltd. on 28-Nov-22
*SANJAY LABROO Promoter & Director Acquisition 13783920 shares of Asahi India Glass Ltd.
*Ashapura Industrial Finance Limited Promoter Group Acquisition 5000 shares of Ashapura Minechem Ltd. on 29-Nov-22
*VINTEX TOOLS PRIVATE LIMITED Promoter Group Acquisition 3000 shares of Shakti Pumps (India) Ltd.-$ on 29-Nov-22
*Mahendra N Sha Director Acquisition 1000000 shares of Idfc Limited on 30-Nov-22
*Spicebulls Investments Limited Promoter Group Disposal 19780 shares of Godfrey Phillips India Ltd.
*Jayanthi Puljal Promoter Disposal 15000 shares of Pennar Industries Ltd.-$ on 29-Nov-22
*Siddeshwari Tradex Private Limited Promoter Group Pledge 1000000 shares of Jindal Steel & Power Ltd. on 29-Nov-22
*SURAJ FINVEST PRIVATE LIMITED Promoter Group Revoke 221500 shares of Emami Ltd.-$ on 28-Nov-22
*Gujarat Themis Biosyn Ltd. Interim Dividend Rs. 4.4 Ex Date 02-Dec-2022
Stock In Action
VGuard Industries: Since its incorporation, VGuard has diversified its product portfolio and established itself as a pan-India fast-moving electric goods (FMEG) player, with 14% sales growth over the last decade. In electronics, company is the market leader and dominates the stabiliser category. There is a positive correlation between the sales of stabilisers and air-conditioners, televisions and refrigerators as it ensures safe and secure power supply for efficient functioning of devices. The business is well-established in the market for water heaters (electric and solar). Another growing product in this segment is fans, where it has increased its market share over a period by expanding its distribution reach and is now expanding its product portfolio by moving up in premium products. The company has been able to maintain EBITDA margins in the 9-11% range on account of various cost-optimisation measures and operational efficiencies. Going forward, the management expects the operating margins to be around 10-11% for the next few years. Positive on VGuard given its financial track record, business strategy and competitive market positioning.
JB Chemicals & Pharmaceuticals: JB Chemicals & Pharmaceuticals announced that it has received ANDA approval from the USFDA for Venlafaxine Extended Release Tablets 37.5mg, 75mg, 150mg and 225mg. This product is based on OROS (Osmotic Controlled Release Oral Delivery System) technology, an advanced and precision-controlled release mechanism. The generic product approval is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Venlafaxine Hydrochloride Extended-Release Tablets, 37.5 mg, 75 mg, 150 mg, and 225 mg, of Osmotica Pharmaceutical U.S. LLC. As per IQVIA Health MAT Oct 2022 data, Venlafaxine Extended-Release tablets recorded annualized sales of approximately $ 48 million in the US. Positive on JB Chemicals & Pharmaceuticals as the Venlafaxine drug has good amount of market in US and the approval will help in improving its US sales.